| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Viral P Patel, Anthony Feinstei. Cannabis and cognitive functioning in multiple sclerosis: The role of gender. Multiple sclerosis journal - experimental, translational and clinical. vol 3. issue 2. 2020-10-01. PMID:28634543. |
cognitive function in people with multiple sclerosis (pwms) is associated with gender differences and the use of smoked/ingested cannabis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Stacey S Cofield, Amber Salter, Tuula Tyry, Christina Crowe, Gary R Cutter, Robert J Fox, Ruth Ann Marri. Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants. Neurology. Clinical practice. vol 7. issue 4. 2020-10-01. PMID:29185555. |
interest in and use of marijuana by persons with multiple sclerosis (ms) has increased. |
2020-10-01 |
2023-08-13 |
human |
| Katja Akgün, Ute Essner, Cordula Seydel, Tjalf Ziemsse. Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies. Journal of central nervous system disease. vol 11. 2020-10-01. PMID:30886530. |
daily practice managing resistant multiple sclerosis spasticity with delta-9-tetrahydrocannabinol: cannabidiol oromucosal spray: a systematic review of observational studies. |
2020-10-01 |
2023-08-13 |
Not clear |
| Khadesia Howell, Alexandria Washington, Paula M Williams, Arlesia L Mathis, John S Luqu. Medical Marijuana Policy Reform Reaches Florida: A Scoping Review. Florida public health review. vol 16. 2020-10-01. PMID:31891164. |
florida became the first state in the u.s. south to legalize the use of medical marijuana to treat a variety of health conditions including chronic pain, epilepsy, and spasticity symptoms from multiple sclerosis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Gordon D Ko, Sara L Bober, Sean Mindra, Jason M Morea. Medical cannabis - the Canadian perspective. Journal of pain research. vol 9. 2020-09-30. PMID:27757048. |
this review also includes case studies demonstrating the use of medical marijuana by patients with neuropathic low-back pain, neuropathic pain in fibromyalgia, and neuropathic pain in multiple sclerosis. |
2020-09-30 |
2023-08-13 |
Not clear |
| Wesley K Utomo, Marjan de Vries, Henri Braat, Marco J Bruno, Kaushal Parikh, Mònica Comalada, Maikel P Peppelenbosch, Harry van Goor, Gwenny M Fuhle. Modulation of Human Peripheral Blood Mononuclear Cell Signaling by Medicinal Cannabinoids. Frontiers in molecular neuroscience. vol 10. 2020-09-30. PMID:28174520. |
medical marijuana is increasingly prescribed as an analgesic for a growing number of indications, amongst which terminal cancer and multiple sclerosis. |
2020-09-30 |
2023-08-13 |
human |
| Sheila Gupta, Kelly Fellows, Bianca Weinstock-Guttman, Jesper Hagemeier, Robert Zivadinov, Murali Ramanatha. Marijuana Use by Patients with Multiple Sclerosis. International journal of MS care. vol 21. issue 2. 2020-09-30. PMID:31049035. |
with social attitudes about marijuana changing and patients sometimes seeking nonmainstream treatment options, the main goal of this study was to investigate the prevalence of, and factors associated with, marijuana use by patients with multiple sclerosis (ms). |
2020-09-30 |
2023-08-13 |
Not clear |
| Thorsten Rudroff, Jacob Sosnof. Cannabidiol to Improve Mobility in People with Multiple Sclerosis. Frontiers in neurology. vol 9. 2020-09-29. PMID:29623067. |
cannabidiol to improve mobility in people with multiple sclerosis. |
2020-09-29 |
2023-08-13 |
Not clear |
| Zinah Zamil Al-Ghezi, Philip Brandon Busbee, Hasan Alghetaa, Prakash S Nagarkatti, Mitzi Nagarkatt. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain, behavior, and immunity. vol 82. 2020-08-25. PMID:31356922. |
currently, a combination of marijuana cannabinoids including delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) is used as a drug to treat muscle spasticity in patients with multiple sclerosis (ms). |
2020-08-25 |
2023-08-13 |
mouse |
| Tjalf Ziemsse. Tetrahydrocannabinol: cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity: newest evidence. Neurodegenerative disease management. vol 9. issue 2s. 2020-08-18. PMID:30657019. |
tetrahydrocannabinol: cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity: newest evidence. |
2020-08-18 |
2023-08-13 |
Not clear |
| b' Jolana Markov\\xc3\\xa. Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from randomized clinical trials. Neurodegenerative disease management. vol 9. issue 2s. 2020-08-18. PMID:30657024.' |
subsequent to ema approval of tetrahydrocannabinol (thc): cannabidiol (cbd) oromucosal spray based on results of various studies, including an enriched-design clinical trial, two newer postapproval randomized trials have confirmed its efficacy and safety for treating resistant multiple sclerosis spasticity, while simultaneously addressing specific authorities' concerns. |
2020-08-18 |
2023-08-13 |
Not clear |
| Anthony Feinstein, Cecilia Meza, Cristiana Stefan, Richard W Staine. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. Brain : a journal of neurology. vol 142. issue 9. 2020-05-12. PMID:31363742. |
coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. |
2020-05-12 |
2023-08-13 |
human |
| Anthony Feinstein, Cecilia Meza, Cristiana Stefan, Richard W Staine. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. Brain : a journal of neurology. vol 142. issue 9. 2020-05-12. PMID:31363742. |
to address this question, 40 patients with multiple sclerosis who started using cannabis after the onset of multiple sclerosis and who used it for at least 4 days a week over many years were divided by odd-even number selection into two groups: cannabis continuation and cannabis withdrawal. |
2020-05-12 |
2023-08-13 |
human |
| Anthony Feinstein, Cecilia Meza, Cristiana Stefan, Richard W Staine. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. Brain : a journal of neurology. vol 142. issue 9. 2020-05-12. PMID:31363742. |
these results reveal that patients with multiple sclerosis who are frequent, long-term cannabis users can show significant improvements in memory, processing speed and executive function after 28 days of drug abstinence. |
2020-05-12 |
2023-08-13 |
human |
| Anthony Feinstein, Cecilia Meza, Cristiana Stefan, Richard W Staine. Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis. Brain : a journal of neurology. vol 142. issue 9. 2020-05-12. PMID:31363742. |
the absence of similar improvements in a matched multiple sclerosis group that remained on cannabis shows that beneficial cognitive change after stopping cannabis is not solely attributable to the effects of practice. |
2020-05-12 |
2023-08-13 |
human |
| Iris-Katharina Penner, Hans-Peter Hartun. The dark side of the moon: looking beyond beneficial effects of cannabis use in multiple sclerosis. Brain : a journal of neurology. vol 142. issue 9. 2020-05-05. PMID:31497861. |
the dark side of the moon: looking beyond beneficial effects of cannabis use in multiple sclerosis. |
2020-05-05 |
2023-08-13 |
Not clear |
| Jose F Téllez-Zenteno, Lady D Ladino, Lizbeth Hernández-Ronquill. The Use of Cannabis as a Treatment for Epilepsy in Adult Patients: Are Side Effects a Limitation of Use? Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895185. |
cannabis has been widely used to treat many medical conditions such as multiple sclerosis symptoms, mood disorders, pain, sleep disorders, and seizures among others. |
2020-03-18 |
2023-08-13 |
Not clear |
| Khalid A Jadoon, Garry D Tan, Saoirse E O'Sulliva. A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI insight. vol 2. issue 12. 2020-03-09. PMID:28614793. |
cannabidiol (cbd) is a nonpsychoactive phytocannabinoid used in multiple sclerosis and intractable epilepsies. |
2020-03-09 |
2023-08-13 |
human |
| S Gustavsen, H B Søndergaard, S R Andresen, M Magyari, P S Sørensen, F Sellebjerg, A B Otura. Illegal cannabis use is common among Danes with multiple sclerosis. Multiple sclerosis and related disorders. vol 33. 2020-01-13. PMID:31129415. |
illegal cannabis use is common among danes with multiple sclerosis. |
2020-01-13 |
2023-08-13 |
Not clear |
| S Gustavsen, H B Søndergaard, S R Andresen, M Magyari, P S Sørensen, F Sellebjerg, A B Otura. Illegal cannabis use is common among Danes with multiple sclerosis. Multiple sclerosis and related disorders. vol 33. 2020-01-13. PMID:31129415. |
use of cannabis to alleviate multiple sclerosis (ms)-related symptoms is increasing. |
2020-01-13 |
2023-08-13 |
Not clear |